Analysis of Differences in Chitosan Nanoparticle Preparations
on the Inhibitory Power of Bacteria in the Oral Cavity
Tri Wiyatini1*, Hermien Nugraheni2,
Irmanita Wiradona3, Aryadiva N. Prayoga4
1,2,3,4Poltekkes Kemenkes
Semarang, Semarang, Indonesia
Email: triwiyatini@gmail.com1, hermienprajoga@poltekkes-smg.ac.id2,
irmanita.wiradona@gmail.com3, divaprayoga988@gmail.com4
KEYWORDS |
ABSTRACT |
Chitosan
Nanoparticles, Oral Cavity Antibacterial. |
The
oral cavity serves as a primary habitat for various bacteria, which can lead
to oral health issues such as caries, periodontal disease, and thrush.
Chitosan nanoparticles are known for their antibacterial properties and have
potential as agents to inhibit bacterial growth in the oral cavity. This
study aims to evaluate and compare the antibacterial efficacy of chitosan
nanoparticles at different concentrations (1%, 2%, and 3%) against specific
oral bacteria, including Streptococcus mutans (caries-causing
bacteria), Porphyromonas gingivalis (periodontal disease bacteria),
and Streptococcus sanguinis (thrush bacteria). A true experimental
design was applied with in vitro testing on bacterial cultures, followed by
in vivo testing on male Wistar rats aged 4 months to observe practical
efficacy. The most effective concentration was then formulated into three
dosage forms: gel, toothpaste, and solution. Data analysis was conducted
using ANOVA, followed by Duncan's Multiple Range Test to compare the
inhibitory effects across the formulations. Results indicated that the 3%
chitosan mouthwash had the highest bacterial inhibitory effect, with an
inhibition zone of 1.30 cm, outperforming other formulations, while the 1.5%
chitosan gel showed the lowest efficacy at 0.91 cm. These findings suggest
that different chitosan formulations exhibit varying levels of antibacterial
activity, with 3% chitosan mouthwash demonstrating the most potential. This
research highlights the implications of chitosan nanoparticles as effective
antibacterial agents in oral care products, promoting future exploration of
chitosan-based formulations for improved oral health solutions. |
DOI: 10.58860/ijsh.v3i11.256 |
|
Corresponding Author: Tri Wiyatini*
Email: triwiyatini@gmail.com
INTRODUCTION
The oral
cavity is one part of the body that must be kept healthy. Maintaining oral
health has indirectly reduced the risk of contracting diseases that concern
bodily health, especially oral health, because some diseases have symptoms that
can be seen from the condition of the mouth
Based on the
2016 Global Burden of Disease Study, dental and oral health problems are a
disease experienced by almost half of the world's population, namely 3.58
billion people. According to Basic Health Research, in 2018, the proportion of
dental and oral problems in Indonesia reached 956,045 people
The oral
cavity is home to various microorganisms, including bacteria that can have both
positive and negative effects. Disruptions in the balance of these
microorganisms, often caused by unhealthy eating habits and the use of
dentures or braces, can lead to changes in the microbial composition of the
oral cavity. One of the dominant bacteria involved in plaque formation and a
major cause of dental caries is the Gram-positive cocci, specifically
Streptococcus sp. Other bacteria commonly found as part of the oral flora
include Staphylococcus sp., Lactobacillus sp., and Bacillus sp. Even though
these bacteria are normally harmless, under certain conditions, they can become
pathogenic and lead to infections
Staphylococcus
sp., in particular, is a common inhabitant of the oral cavity and has been
identified as a significant pathogen in cases of infection. National
surveillance involving eight major referral hospitals in Indonesia revealed
that the prevalence of infections caused by Staphylococcus sp. remains high,
ranging from 25% to 65%, with a national average of 38%
Chitosan
nanoparticles were specifically chosen for this study due to their proven
antimicrobial properties and biocompatibility. Unlike traditional antibiotics,
chitosan nanoparticles offer a targeted approach to reducing pathogenic
bacterial growth while minimizing side effects and resistance. Their nano-sized
particles enhance interaction with bacterial cell walls, particularly effective
against Staphylococcus sp. and Streptococcus sp. This makes chitosan
nanoparticles an ideal candidate for developing new treatments to prevent and
manage infections in the oral cavity. Research into this area is important as
it addresses the growing concern over antibiotic resistance and provides an
alternative solution for combating infections safely and sustainably
To overcome
this problem, it is necessary to look for alternative antibacterial drugs for
the oral cavity and teeth. Indonesia is a tropical country that has high
biodiversity and is rich in flora and fauna, which can be used as an
alternative natural treatment. One of the marine biota products is chitosan.
Chitosan is a polysaccharide obtained from the deacetylation of chitin
METHOD
This type of research is a true experiment, by
conducting a micro laboratory examination to test the inhibitory power of
chitosan nanoparticles with a concentration of 1%, 2%, and 3% against several
types of bacteria, including streptococcus mutant (caries bacteria), Porphyromonas
gingivalis (periodontal disease bacteria), Streptococcus sanguinis
(Thrush bacteria). The research population was male Wistar rats aged 4 months.
The concentration with the highest bacterial inhibitory power will be formed as
a preparation. Chitosan will be formed into 3 dosage forms: gel, toothpaste,
and solution. The data analysis used to test differences in bacterial
inhibitory power according to chitosan nanoparticle preparations was ANOVA and
continued with Duncan's Multiple Range Test
RESULT AND DISCUSSION
Bacterial Inhibitory Power
According to Type of Treatment
Table
1. Bacterial Inhibitory Power According to Type of Treatment
Chitosan Nanoparticles Preparate |
n |
Bacterial Inhibitory Power (cm) |
||
Chitosan Gel 1% |
4 |
0.74 |
± |
0.004 |
Chitosan Gel 1.5% |
4 |
0.91 |
± |
0.005 |
Chitosan Gel 2% |
4 |
1.15 |
± |
0.010 |
Chitosan Gel 3% |
4 |
1.28 |
± |
0.005 |
Chitosan Gargle 1% |
4 |
0.68 |
± |
0.015 |
Chitosan Gargle 1.5% |
4 |
0.81 |
± |
0.006 |
Chitosan Gargle 2% |
4 |
1.13 |
± |
0.004 |
Chitosan Gargle 3% |
4 |
1.30 |
± |
0.006 |
Chitosan Toothpaste 1% |
4 |
0.00 |
± |
0.000 |
Chitosan Toothpaste 1.5% |
4 |
0.72 |
± |
0.013 |
Chitosan Toothpaste 2% |
4 |
0.90 |
± |
0.006 |
Chitosan Toothpaste 3% |
4 |
1.01 |
± |
0.008 |
Pathogenic
bacteria in the oral cavity can be prevented with preventive measures such as
administering gel, paste, and gargling chitosan nanoparticles. Chitosan is a
material that can inhibit bacteria, limit the growth of germs, and kill
pathogenic germs. Chitosan is derived from the deacetylation process of chitin,
which is usually found in many marine animals, such as crabs and shrimp.
Chitosan with different concentrations and in different dosage forms allows for
differences in bacterial inhibitory power
Bacterial Inhibitory Power
According to The 5 Best Treatment
Of the 12 types of Chitosan nanoparticle preparations, the top 5 have
bacterial inhibitory power ranging from 0.91-1.30 cm. The difference in
bacterial inhibitory power according to the Chitosan nanoparticle preparation
was tested using ANOVA and continued with Duncan's Multiple Range Test. There
was a significant difference in bacterial inhibitory power (p<0.001) between
the 5 types of nanoparticle preparations with various chitosan concentrations,
then the Duncan's Multiple Range Test was carried out as presented in Table 2.
Table 2. Bacterial
Inhibitory Power According to The 5 Best Treatment
Bacterial Inhibitory Power (cm) |
|||
Chitosan Nanoparticles Preparate |
Mean |
SD |
|
Chitosan Gel 1.5% |
0.91 |
0.005 |
a |
Chitosan gargle 3% |
1.01 |
0.008 |
b |
Chitosan Gargle 2% |
1.13 |
0.005 |
c |
Chitosan Gel 2% |
1.15 |
0.013 |
d |
Chitosan toothpaste 3% |
1.30 |
0.006 |
e |
Values are maens±standard deviation, means with different
superscripts along the same column are significantly different (p < 0.05);
the superscript alphabets ’’a-e’’ separates the means obtained from ANOVA
using Duncan’s Multiple Range Test |
Table
2 shows that there is a significant difference in inhibitory power between the
5 types of Chitosan nanoparticle preparations (p<0.05). Of the top 5
rankings, the 1.5% Chitosan Gel nanoparticle preparation has the lowest
bacterial inhibitory power, namely 0.91, and the 3% Chitosan Mouthwash
nanoparticle preparation has the highest bacterial inhibitory power, namely
1.30, which can beat the 2% Chitosan Gel nanoparticle preparation. In
inhibiting bacteria, 3% Chitosan toothpaste is better than 1.5% Chitosan Gel.
Likewise, 2% chitosan mouthwash is better than 3% chitosan toothpaste.
As time goes
by, dental and oral health problems are increasing. One of the dental and oral
health problems that often occurs in Indonesia is dental caries
Bacteria in
the mouth are dangerous because they cause several dental and oral diseases.
These bacteria actually won't be a problem if their numbers are balanced and
live in harmony. However, the emergence of oral health problems, such as caries
(cavities), gum disease (periodontitis), or infection, is caused by the
presence of bacteria
According to
Basic Health Research (RISKESDAS, Riset Kesehatan Dasar) data, there
were 57.6% cavities, and the incidence of cavities has increased compared to
2013
One of them is
making an oral cleansing solution that has antibacterial ingredients that cause
dental caries, whereas Streptococcus mutans bacteria is one of the
bacteria that causes dental caries
Chitosan is a
polysaccharide obtained from the deacetylation of chitin, which generally comes
from crustacean animal skin waste. Chitosan has relatively more reactive
properties than chitin and is easily produced in the form of a solution,
powder, paste, film, and fibre. Chitosan is a bioactive material and its
activity can be applied in the pharmaceutical, agricultural, and industrial
environments. Chitosan, as a bioactive material, can inhibit the growth of Streptococcus
mutans bacteria
Chitosan
compounds can kill bacteria by damaging cell membranes. Chitosan has a specific
form containing an amino group in its carbon chain, which is positively charged
so that in the liquid state, it is sensitive to high ionic strength
The use of
chitosan as an antibacterial agent against the growth of natural Streptococcus
mutans bacteria has advantages compared to synthetic chemical antibacterial
agents, namely, its toxic power is lower and safer if ingested in certain
amounts
CONCLUSION
Chitosan derived
from shrimp shells containing chitin, possesses antibacterial properties.
Various concentrations of chitosan nanoparticles have been found to exhibit
inhibitory effects against Porphyromonas bacteria. Different nanoparticle
formulations with varying chitosan proportions demonstrate bacterial inhibition
ranging from 0.00 to 1.30 cm, with 1% chitosan paste showing no bacterial
inhibition, while a 3% chitosan mouthwash can inhibit bacterial growth by 1.30
cm. As a research contribution for the future, this study opens up
opportunities for further exploration of the formulation and application of
chitosan in the health sector, especially in the development of environmentally
friendly and more effective antibacterial products. In addition, further
research can be focused on modifying and improving the efficacy of chitosan,
such as increasing the size of nanoparticles or adding other synergistic
ingredients to enhance antibacterial activity against various types of
pathogenic bacteria. The implementation of chitosan in health products, such as
mouthwash, toothpaste, or wound dressings, could also be the focus of research
to see its impact on a clinical scale, potentially improving public health and
reducing dependence on antibiotics.
REFERENCES
Bhambri, T. (2020). Role of Oral Microbial Flora in Health and Illness. Journal
of Advanced Medical and Dental Sciences Research, 8(3), 53–60.
Cakasana, N., Suprijanto, J., & Sabdono, A. (2014). Aktivitas
Antioksidan Kitosan yang Diproduksi dari Cangkang Kerang Simping (Amusium sp)
dan Kerang Darah (Anadara sp). Journal of Marine Research, 3(4),
395–404.
Damayanti, W., Rochima, E., & Hasan, Z. (2016). Application of
chitosan as antibacterial for Pangasius fillet at low temperature storage. Jurnal
Pengolahan Hasil Perikanan Indonesia, 19(3), 321–328.
Elgreu, T., Lee, S., Wen, S., Elghadafi, R., Tangkham, T., Ma, Y., Liu,
B., Dibart, S., & Tang, X. (2022). The pathogenic mechanism of oral
bacteria and treatment with inhibitors. Clinical and Experimental Dental
Research, 8(1), 439–448.
Fauziyyah, J. S. (2024). Uji Daya Hambat Antibakteri Nanopartikel
Ekstrak Etanol Bunga Telang (Clitoria Ternatea) Terhadap Bakteri Escherichia coli
(E. coli).
Gajdács, M., Urbán, E., Stájer, A., & Baráth,
Z. (2021). Antimicrobial
resistance in the context of the sustainable development goals: A brief
review. European Journal of Investigation in Health, Psychology and
Education, 11(1), 71–82.
Hajardhini, P., Susilowati, H., & Yulianto, H. D. K. (2020). Rongga
mulut sebagai reservoir potensial untuk infeksi Pseudomonas aeruginosa. Odonto:
Dental Journal, 7(2), 125–133.
Kaligis, F. R. (2017). Identifikasi bakteri pada
plak gigi pasien di Puskesmas Bahu dan uji resistensi terhadap antibiotik
kloramfenikol dan linkosamida (klindamisin). Pharmacon, 6(3).
Khan, R. A., Devi, K. R., Pratim Barman, M., Bhagawati, M., &
Sarmah, R. (2023). Bacteria in the oral cavity of individuals consuming
intoxicating substances. PLOS ONE, 18(5),
e0285753. https://doi.org/10.1371/journal.pone.0285753
Khasanah, I. H., Sae-Sia, W., & Damkliang, J.
(2019). The
effectiveness of oral care guideline implementation on oral health status in
critically ill patients. SAGE Open Nursing, 5, 2377960819850975.
Nanggita, P. P., Mu’arofah, B., Imasari, T., & Santoso, K. (2023).
Deteksi Bakteri Staphylococcus sp. pada Swab Rongga Mulut Mahasiswa D3 TLM IIK
Bhakti Wiyata Kediri yang Memakai Kawat Gigi. Jurnal Sintesis: Penelitian
Sains, Terapan Dan Analisisnya, 4(1).
Ong, T. H., Chitra, E., Ramamurthy, S., Siddalingam, R. P., Yuen, K. H.,
Ambu, S. P., & Davamani, F. (2017). Chitosan-propolis nanoparticle
formulation demonstrates anti-bacterial activity against Enterococcus faecalis
biofilms. PloS One, 12(3), e0174888.
Paomephan, P., Assavanig, A., Chaturongakul, S., Cady, N. C., Bergkvist,
M., & Niamsiri, N. (2018). Insight into the antibacterial property of
chitosan nanoparticles against Escherichia coli and Salmonella Typhimurium and
their application as vegetable wash disinfectant. Food Control, 86,
294–301. https://doi.org/10.1016/j.foodcont.2017.09.021
Riskesdas, T. (2019). Laporan nasional RISKESDAS 2018. Jakarta: Badan
Penelitian Dan Pengembangan Kesehatan.
Rusdi, B., Aryani, R., & Yuniarni, U. (2023). Aktivitas Prebiotik
Pisang Serta Efeknya Terhadap Kesehatan Dan Penyakit. Jurnal Ilmiah Farmasi
Farmasyifa, 6(2), 172–186.
Sundari, D., & Almasyhuri, A. (2019). Uji aktivitas antiseptik
ekstrak etanol daun sirih (Piper betle Linn.) dalam obat kumur terhadap
Staphylococcus aureus secara in Vitro. Jurnal
Kefarmasian Indonesia, 10–18.
Tenorio-Soto, K., Gutiérrez-Marín, N.,
Ramírez-Mora, T., & Altamirano-Silva, P. (2024). Microbiota of dental caries in
primary teeth of a Costa Rican Child population. Odovtos-International
Journal of Dental Sciences, 26(1), 130–138.
Valm, A. M. (2019). The Structure of Dental Plaque Microbial Communities
in the Transition from Health to Dental Caries and Periodontal Disease. Journal
of Molecular Biology, 431(16), 2957–2969.
https://doi.org/10.1016/j.jmb.2019.05.016
Wihardja, R., & Setiadhi, R. (2018). Kondisi kesehatan gigi dan
mulut siswa SDK Yahya. Jurnal Kedokteran Gigi Universitas Padjadjaran, 30(1),
26–32.
Yilmaz Atay, H. (2019). Antibacterial activity of chitosan-based
systems. Functional Chitosan: Drug Delivery and Biomedical Applications,
457–489.
|
|